20 December 2005
Schering-Plough Animal Health Corporation has launched a new web site to keep the U.S. aquaculture industry abreast of the latest developments with AQUAFLOR® (florfenicol), the first antibiotic approved for use on U.S. fish farms in more than 20 years. The site can be accessed at www.AQUAFLOR-USA.com.
Produced specifically for the U.S. market, www.AQUAFLOR-USA.com includes a Newsroom section, where the industry can access educational articles about aquatic disease management and the latest announcements concerning the product. The Newsroom section also features company news releases and AquaFAQs, a new series of question-and-answer documents designed the answer the most frequently asked questions about the product.
Producers can also use the web site to access HTML and downloadable PDF versions of product literature, as well as a handbook on using Veterinary Feed Directive (VFD) drugs, an exclusive status FDA assigned to AQUAFLOR and to all new in-feed drugs to ensure correct usage and long-term effectiveness. VFD forms required by FDA are also available for downloading.
The site’s Scientific Articles section features a downloadable PDF file of the AQUAFLOR Monograph, which summarizes all major U.S. trials conducted to date to support the product’s use in catfish, as well as links to several technical articles presented by scientists at industry meetings in recent years. An Industry Links page allows quick access to additional information from industry support services and the news media serving U.S. aquaculture.
AQUAFLOR Type A Medicated Article is a fast-acting, broad-spectrum, highly palatable antibiotic premix developed specifically for aquaculture. It has been used worldwide to treat highly infectious bacterial diseases in salmon, trout and other farm-raised aquatic species. It was recently approved in the United States for controlling mortality in catfish due to enteric septicemia (ESC) associated with Edwardsiella ictaluri. Schering-Plough Animal Health is pursuing additional claims for use in other farm-raised aquatic species produced in the United States.
Schering-Plough Animal Health Corporation is the worldwide animal health business of Schering-Plough Corporation (NYSE: SGP) of Kenilworth, N.J. Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, veterinarians, patients and customers served by its more than 30,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
AQUAFLOR is a registered trademark of Schering-Plough Veterinary Corporation.
